7.3 IBS and IBD Flashcards
Who usually gets IBS?
Females, 25-44
What is the ROME III classifications of IBS?
3 months or more
Abdominal discomfort/pain at least 3d/month
Relieved by defecation
Associated with a change in stool appearance or form and frequency
What are the new onset alarm symptoms of IBS?
> 40
GI bleeding
Weight loss or other evidence of malnutrition
Fever
Significant family history of GI disease
O/E abdominal mass or abnormality
Anaemia, blood test abnormalities
What are the symptoms of IBS?
Abnormal frequency (>3/day <3/week) Abnormal stool form Abnormal passage Passage of mucus bloating
What are the management options for IBS?
Patient based groups Dietary therapy: food diary, dietician, FODMAP exclusion, high fibre Psychological therapy Loperamide for diarrhoea Probiotics or antibiotics
What is FODMOAPS and what is the purpose
Fermentable Oligo-, Di-, Mono-saccharides And Polyols
Aim is to reduce the distension of the small and large intestine that these molecules can cause thus reducing the pain and bloating associated with functional gastrointestinal disorder
What are the genetic components of Chron’s and UC?
Chrons: over 70 genetic loci identified
UC: weaker association
What is the distribution of chrons and UC?
Chrons: Anywhere along the GIT
UC: colon and continuous
Do you see perianal disease in Chron’s and UC?
Yes in Chon’s
What is the pathology of chrons and UC?
Chrons: full thickness of bowel wall, macrophages and granulomata
UC: superficial (epithelium) and plasma cells
What is the presentation of ulcerative colitis?
Proctitis: urgency, bleeding, discomfort
diarrhoea mixed with blood and mucus
What are the symptoms and signs of severe UC?
>6 bloody stools/day Fever Tachycardia Anaemia Leucocytosis Elevated ESR Hypoalbuminaemia
What are the potential complications of UC?
Fulminant colitis Toxic megacolon Perforation Peritonitis Haemorrhage Dysplasia and cancer
What is the current treatment options for UC?
5-asa: Sulfasalazine Steroids: Prednisolone Immunosuppressive AZA/6-MP: Azathioprine Monoclonal antibodies: Infliximab Surgery
What is the mechanism for sulfaslazine (5-ASA drugs)
In Crohn’s disease and ulcerative colitis, it is thought to be an antinflammatory drug that provides topical relief inside the intestine. It does this via a number of mechanisms such as reducing the synthesis of inflammatory mediators known as eicosanoids and inflammatory cytokines